Annu Rev Med

• 

  Publication Venue For

  • New Approaches to Glioblastoma..  73:279-292. 2022
  • SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment..  73:1-16. 2022
  • Advances in Human Lung Transplantation..  72:135-149. 2021
  • New Therapeutics for Hepatitis B: The Road to Cure..  72:93-105. 2021
  • The Role of Exercise in Management of Mental Health Disorders: An Integrative Review..  72:45-62. 2021
  • Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer..  72:399-413. 2021
  • Molecular Diagnostics for Mycobacterium tuberculosis Infection..  70:77-90. 2019
  • Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation..  70:61-75. 2019
  • New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance..  69:379-394. 2018
  • Recombinant Poliovirus for Cancer Immunotherapy..  69:289-299. 2018
  • Gene Editing: A New Tool for Viral Disease..  68:401-411. 2017
  • Nonalcoholic Steatohepatitis..  68:85-98. 2017
  • Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs..  68:345-358. 2017
  • Cystic Neoplasms of the Pancreas..  67:45-57. 2016
  • Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?.  66:241-253. 2015
  • The DNA damage response: implications for tumor responses to radiation and chemotherapy..  66:129-143. 2015
  • Adaptive clinical trial design..  65:405-415. 2014
  • Recent progress in HIV-associated nephropathy..  63:147-159. 2012
  • Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies..  62:265-279. 2011
  • Heparin-induced thrombocytopenia..  61:77-90. 2010
  • The expanded biology of serotonin..  60:355-366. 2009